Pulse Biosciences (PLSE) Asset Writedowns and Impairment (2022)
Pulse Biosciences (PLSE) posted quarterly Asset Writedowns and Impairment of $1.1 million for Q4 2022.
Pulse Biosciences (PLSE) Asset Writedowns and Impairment (2022) Analysis & Trends
Pulse Biosciences' Asset Writedowns and Impairment history runs 1 years deep, the most recent figure standing at $1.1 million for Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn |
| 10 | Pulse Biosciences | 3.50 Bn | 3.50 Bn | 161,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 1.11 Mn |
| Dec 31, 2022 | 1.11 Mn |